Heranova Lifesciences Revenue and Competitors
Estimated Revenue & Valuation
- Heranova Lifesciences's estimated annual revenue is currently $1.5M per year.
- Heranova Lifesciences's estimated revenue per employee is $140,000
Employee Data
- Heranova Lifesciences has 11 Employees.
- Heranova Lifesciences grew their employee count by 57% last year.
Heranova Lifesciences's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder & CEO | Reveal Email/Phone |
2 | Co-Founder & Chairwoman | Reveal Email/Phone |
3 | Co-Founder | Reveal Email/Phone |
4 | Co-Founder & Chief Development Officer | Reveal Email/Phone |
5 | Chief Business Officer | Reveal Email/Phone |
6 | Chief Medical Officer | Reveal Email/Phone |
7 | Chief Medical Officer – Diagnostics | Reveal Email/Phone |
8 | Director, Medical Affairs and Commercial Development, APAC | Reveal Email/Phone |
9 | Clinical Project Manager | Reveal Email/Phone |
Heranova Lifesciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.5M | 11 | 57% | N/A | N/A |
What Is Heranova Lifesciences?
Heranova Lifesciences is a Boston-based biotech company solely focused on developing integrated care solutions for women’s health issues. They intend to address unmet needs in women’s healthcare through their offerings of internally developed or externally partnered diagnostics, drugs, and devices. The company was founded in June 2022 by a team of serial entrepreneurs and seasoned MNC executives with support from a world class Scientific Advisory Board. They have established a presence in both the United States and Asia.
keywords:N/AN/A
Total Funding
11
Number of Employees
$1.5M
Revenue (est)
57%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1M | 11 | 22% | N/A |
#2 | $1.5M | 11 | -15% | N/A |
#3 | $1M | 11 | -8% | N/A |
#4 | $1M | 12 | -14% | N/A |
#5 | $1M | 12 | 9% | N/A |